DUBLIN--(BUSINESS WIRE)--Jul 24, 2018--The “Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) -- By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)” report has been added to ResearchAndMarkets.com’s offering.
The global market value is projected to display a steady growth represented by a CAGR of 14.36% during the forecast period of 2018 - 2023.
Amongst the regions, Europe accounts for the largest share by value in global Bio CMO market in 2017. Additionally, Asia Pacific will be a growing region in the forecasted period, 2018-2023 as population is increasing along with growing number of pharmaceutical requirements. Growing number of chronic diseases is also supporting the market of Bio CMO industry.
The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Bio CMO market. Additionally, the report also assesses the financial performance and strategies of various companies operating in the Biopharmaceutical CMO market.
Scope of the Report
Global Bio CMO Market (Actual Period: 2013-2017, Forecast Period: 2018-2023Global Bio CMO Market - By value By Type - Mammalian & Microbial
Regional Markets - North America, Europe, APAC (Actual Period: 2013-2017, Forecast Period: 2018-2023)Bio CMO Market - By value
Country Analysis - U.S, Denmark, Germany, Switzerland, Korea, Japan, China and OthersBio CMO Market - By value
Other Report HighlightsMarket Dynamics - Drivers and Restraints Company Analysis - Lonza, Boehringer Ingelheium, Samsung Biologics, Wuxi Biologics
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Biopharmaceutical CMO Market Outlook
4. Global Bio CMO Market: Growth and Forecast
5. Global Biopharmaceutical Market: Segment Analysis
6. North America Bio CMO Market: Growth and Forecast
7. U.S Bio CMO Market, By indications
8. Canada Bio CMO Market , By Indications
9. Europe Bio CMO Market: Growth and Forecast
10. Germany Bio CMO Market, By indications
11. U.K Bio CMO Market, By indications
12. France Bio CMO Market, By indications
13. APAC Bio CMO Market: Growth and Forecast
14. China Bio CMO Market, By indications
15. India Bio CMO Market, By indications
16. Japan Bio CMO Market, By indications
17. Bio CMO Market: Country Analysis
18. Global Bio CMO Market Dynamics
19. Company ProfilesLonza Boehringer Ingelheium Samsung Biologics Wuxi Biologics
For more information about this report visit https://www.researchandmarkets.com/research/7rvvhw/global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180724005459/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Biopharmaceuticals ,Pharmaceutical Manufacturing
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/24/2018 07:42 AM/DISC: 07/24/2018 07:42 AM